Individualized supplementation of folic acid according to polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR) reduced pregnant complications

Gynecologic and Obstetric Investigation

Volumn 79, Issue 2, 2015, Pages 107-112

  Li, Xiujuan ^a   Jiang, Jing ^a   Xu, Min ^a   Xu, Mei ^a   Yang, Yan ^a   Lu, Wei ^a   Yu, Xuemei ^a   Ma, Jianlin ^a   Pan, Jiakui ^b  

^a The People's Hospital of Chengyang District   (China)

^b Biomedicine Co Ltd   (China)

Author keywords

Folic acid; Methionine synthase reductase; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GENOMIC DNA; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; VITAMIN B COMPLEX;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINA; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MIDDLE AGED; MOTHER; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; YOUNG ADULT; GENETIC POLYMORPHISM; GENETICS; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME;

ADULT; CHINA; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84924252152     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000367656     Document Type: Article

References (32)

1. Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gulmezoglu AM, Merialdi M: A global reference for fetal-weight and birthweight percentiles. Lancet 2011; 377: 1855-1861.
2. Bakas P, Gregoriou O, Hassiakos D, Liapis A, Creatsas M, Konidaris S: Hysteroscopic resection of uterine septum and reproductive outcome in women with unexplained infertility. Gynecol Obstet Invest 2012; 73: 321-325.
3. Xu L, Shi R: Noninvasive prenatal diagnosis using next-generation sequencing. Gynecol Obstet Invest 2014; 77: 73-77.
4. Scholl TO, Johnson WG: Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000; 71: 1295S-1303S.
5. Wong S, Ordean A, Kahan M: Substance use in pregnancy. J Obstet Gynaecol Can 2011; 33: 367-384.
6. Mutz-Dehbalaie I, Scheier M, Jerabek-Klestil S, Brantner C, Windbichler GH, Leitner H, Egle D, Ramoni A, Oberaigner W: Perinatal mortality and advanced maternal age. Gynecol Obstet Invest 2014; 77: 50-57.
7. Kontic-Vucinic O, Sulovic N, Radunovic N: Micronutrients in women's reproductive health: I. Vitamins. Int J Fertil Womens Med 2006; 51: 106-115.
8. Meka A, Reddy BM: Recurrent spontaneous abortions: an overview of genetic and nongenetic backgrounds. Int J Hum Genet 2006; 6: 109-117.
9. Bogdanova N, Markoff A: Genetic predispositions to thrombophilia associated with recurrent pregnancy loss. J Reprod Med Endocrinol 2008; 5: 101-105.
10. Saetre P, Grove J, Borglum AD, Mors O, Werge T, Andreassen OA, Vares M, Agartz I, Terenius L, Jonsson EG: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population. Am J Med Genet B Neuropsychiatr Genet 2012; 159B:981-986.
11. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ: Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet 1998; 80: 196-198.
12. Brandalize APC, Bandinelli E, Borba JB, Felix TM, Roisenberg I, Schuler-Faccini L: Polymorphisms in genes MTHFR, MTR and MTRR are not risk factors for cleft lip/palate in South Brazil. Braz J Med Biol Res 2007; 40: 787-791.
13. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P: Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp 1994; 181: 180-187; discussion 187-191.
14. Djukic A: Folate-responsive neurologic diseases. Pediatr Neurol 2007; 37: 387-397.
15. Evans SE, Mygind VL, Peddie MC, Miller JC, Houghton LA: Effect of increasing voluntary folic acid food fortification on dietary folate intakes and adequacy of reproductive-age women in New Zealand. Public Health Nutr 2014; 17: 1447-1453.
16. van der Put NM, Eskes TK, Blom HJ: Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 1997; 90: 111-115.
17. Motulsky AG: Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996; 58: 17-20.
18. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
19. Mills JL, Scott JM, Kirke PN, McPartlin JM, Conley MR, Weir DG, Molloy AM, Lee YJ: Homocysteine and neural tube defects. J Nutr 1996; 126: 756S-760S.
20. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM: Maternal plasma folate and vitamin B, are independent risk factors for neural tube defects. Q J Med 1993; 86: 703-708.
21. Chedraui P, Salazar-Pousada D, Villao A, Escobar GS, Ramirez C, Hidalgo L, Perez-Lopez FR, Genazzani A, Simoncini T: Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia. Gynecol Endocrinol 2014; 30: 392-396.
22. Ranganathan P, McLeod HL: Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis. Arthritis Rheum 2006; 54: 1366-1377.
23. Popp RA, Trifa AP, Militaru M, Crisan TO, Petrisor F, Farcas MF, Csernik FA, Pop IV: Methionine synthase reductase (MTRR) gene 66G> a polymorphism as a possible risk factor for recurrent spontaneous abortion. Analele Societatii Nationale de Biologie Celulara 2009; 14: 28.
24. Chmurzynska A, Stachowiak M, Gawecki J, Pruszynska-Oszmalek E, Tubacka M: Protein and folic acid content in the maternal diet determine lipid metabolism and response to high-fat feeding in rat progeny in an age-dependent manner. Genes Nutr 2012; 7: 223-234.
25. Yu G, Wang LG, Han Y, He QY: Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS 2012; 16: 284-287.
26. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE: The epidemiology of diabetes and pregnancy in the US, 1988. Diabetes Care 1995; 18: 1029-1033.
27. Evers IM, De Valk HW, Visser GH: Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328: 915.
28. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M: Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynecol Obstet 2004; 85:S28-S41.
29. Zhang J, Meikle S, Trumble A: Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 2003; 22: 203-212.
30. Wentzel P, Gareskog M, Eriksson UJ: Folic acid supplementation diminishes diabetesand glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005; 54: 546-553.
31. van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ: Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002; 45: 1004-1010.
32. Cechova S, Zeng Q, Billaud M, Mutchler S, Rudy CK, Straub AC, Chi L, Chan FR, Hu J, Griffiths R, et al: Loss of collectrin, an angiotensin-converting enzyme 2 homolog, uncouples endothelial nitric oxide synthase and causes hypertension and vascular dysfunction. Circulation 2013; 128: 1770-1780.